Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Injections, Subcutaneous"" wg kryterium: Temat


Tytuł:
A review of paediatric injectable drug delivery to inform the study of product acceptability - An introduction.
Autorzy:
Ruiz F; ClinSearch, 110 Avenue Pierre Brossolette, 92240 Malakoff, France.
Nunn A; University of Liverpool, Department of Women's and Children's Health, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool L8 7SS, UK.
Gill A; Paediatric Medicines Research Unit, Alder Hey Children's NHSFT, Liverpool L12 2AP, UK.
Clapham D; Independent Pharmaceutical Consultant, 14 Tailors, Bishops Stortford CM23 4FQ, UK.
Fotaki N; Department of Life Sciences, Centre for Therapeutic Innovation (CTI), University of Bath, Claverton Down, Bath BA2 7AY, UK.
Salunke S; European Paediatric Formulation Initiative (EUPFI) School of Pharmacy, University College London, London WC1N 1AX, UK.
Cram A; Pfizer R&D UK Ltd, Ramsgate Road, Sandwich CT13 9ND, UK.
O'Brien F; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin 2, Ireland.
Pokaż więcej
Źródło:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2023 Jul; Vol. 188, pp. 265-270. Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Injections, Subcutaneous*
Humans ; Child ; Administration, Cutaneous ; Administration, Intranasal ; Administration, Intravenous ; Injections, Intramuscular
Czasopismo naukowe
Tytuł:
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis.
Autorzy:
Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Ann and Robert H. Lurie Children's Hospital, Chicago, IL, USA.
Siegfried EC; Saint Louis University School of Medicine, St. Louis, MO, USA.; Cardinal Glennon Children's Hospital, St. Louis, MO, USA.
Cork MJ; Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.; Sheffield Children's Hospital, Sheffield, UK.
Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Eichenfield LF; Departments of Dermatology and Pediatrics, University of California San Diego, La Jolla, CA, USA.
Ramien M; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.; Section of Community Pediatrics, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
Khokhar FA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Chen Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Zhang A; Sanofi, Cambridge, MA, USA.
Cyr SL; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. .; Regeneron Pharmaceuticals Inc., 1 Rockwood Road, Sleepy Hollow, NY, 10591, USA. .
Pokaż więcej
Źródło:
Paediatric drugs [Paediatr Drugs] 2024 Mar; Vol. 26 (2), pp. 163-173. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Bacterial Infections*/complications
Bacterial Infections*/drug therapy
Antibodies, Monoclonal, Humanized*
Child ; Child, Preschool ; Humans ; Antibodies, Monoclonal/therapeutic use ; Treatment Outcome ; Injections, Subcutaneous ; Severity of Illness Index ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
Autorzy:
Comfort AB; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States. Electronic address: .
Alvarez A; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Goodman S; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Upadhyay U; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Mengesha B; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Karlin J; Department of Family and Community Medicine, University of California Davis, Sacramento, CA, United States.
Shokat M; OHSU-PSU School of Public Health, Portland, OR, United States.
Blum M; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Harper CC; Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, CA, United States.
Pokaż więcej
Źródło:
Contraception [Contraception] 2024 Mar; Vol. 131, pp. 110360. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Contraceptive Agents, Female*
COVID-19*
Pregnancy ; Female ; Humans ; United States ; Pandemics ; Injections, Subcutaneous ; Medroxyprogesterone Acetate
Czasopismo naukowe
Tytuł:
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
Autorzy:
Li Y; The First Medical Centre, Chinese PLA General Hospital, Beijing, China.
Cheng Z; The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Lu W; The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China.
Li P; Yuncheng Central Hospital of Shanxi Province, Yuncheng, China.
Jiang H; The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Yang J; The First Hospital of Shanxi Medical University, Taiyuan, China.
Xu J; The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang C; Chongqing SanXia Central Hospital, Chongqing, China.
Zhang L; The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wang Y; Zhongda Hospital Southeast University, Nanjing, China.
Bian F; Cangzhou People's Hospital, Cangzhou, China.
Guo W; The First Hospital of Jilin University, Changchun, China.
Yu X; Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, China.
Chen X; The First Affiliated Hospital of Hainan Medical College, Haikou, China.
Zhao D; Luhe Hospital Affiliated to Capital Medical University, Beijing, China.
Feng B; Shanghai East Hospital, Shanghai, China.
Qu S; Shanghai Tenth People's Hospital, Shanghai, China.
Qin J; Shanxi Provincial People's Hospital, Taiyuan, China.
Zhang Y; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Wang L; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Cheng H; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Mu Y; The First Medical Centre, Chinese PLA General Hospital, Beijing, China.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Mar; Vol. 26 (3), pp. 1057-1068. Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Hypoglycemic Agents*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Adult ; Humans ; Body Weight ; Obesity/complications ; Obesity/drug therapy ; Obesity/chemically induced ; Injections, Subcutaneous ; China/epidemiology ; Double-Blind Method ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real-life multicentric observational study.
Autorzy:
De Greef A; Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Ghislain PD; Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
de Montjoye L; Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Adriaenssens K; Private Dermatologist, Schoten, Belgium.
Bulinckx A; Department of Dermatology, Grand Hôpital de Charleroi, Charleroi, Belgium.
Colmant C; Department of Dermatology, UZ Leuven, Leuven, Belgium.
Cuvelier M; Department of Dermatology, Clinique Notre-Dame de Grâce, Gosselies, Belgium.
Deleu H; Private Dermatologist, Genk, Belgium.
Goeteyn M; Department of Dermatology, AZ Sint-Jan, Brugge, Belgium.
Janssens P; Private Dermatologist, Libramont, Belgium.
Kul A; Department of Dermatology, CHU Saint-Pierre, Brussels, Belgium.
Roquet-Gravy C; Department of Dermatology, Grand Hôpital de Charleroi, Charleroi, Belgium.
Stragier I; Private Dermatologist, Lauwe, Belgium.
Baeck M; Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Pokaż więcej
Źródło:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Mar; Vol. 38 (3), pp. e288-e290. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Observational Study; Letter
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Humans ; Adolescent ; Antibodies, Monoclonal/therapeutic use ; Injections, Subcutaneous ; Treatment Outcome ; Severity of Illness Index ; Double-Blind Method
Raport
Tytuł:
Plasma pharmacokinetics of clorsulon following administration of a single subcutaneous or intravenous injection to cattle.
Autorzy:
Rehbein S; Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Rohrdorf, Germany.
Kvaternick V; Boehringer Ingelheim Animal Health USA, Inc., North Brunswick Research Center, North Brunswick, New Jersey, USA.
Kellermann M; Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Rohrdorf, Germany.
Hamel D; Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Rohrdorf, Germany.
Antretter A; Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Rohrdorf, Germany.
Johnson C; Boehringer Ingelheim Animal Health USA, Inc, Duluth, Georgia, USA.
Pokaż więcej
Źródło:
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2024 Mar; Vol. 47 (2), pp. 87-94. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ivermectin*
Sulfanilamides*/therapeutic use
Animals ; Male ; Cattle ; Female ; Injections, Intravenous/veterinary ; Injections, Subcutaneous/veterinary ; Area Under Curve ; Body Weight
Czasopismo naukowe
Tytuł:
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial.
Autorzy:
Cork MJ; Sheffield Children's Hospital, Sheffield, UK; Sheffield Dermatology Research, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. .
Lockshin B; US Dermatology Partners, Rockville, MD, USA; Georgetown University, Washington, DC, USA.
Pinter A; Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.
Chen Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Shumel B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Prescilla R; Sanofi, Cambridge, MA, USA.
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2024 Feb 12; Vol. 104, pp. adv13467. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Dermatitis, Atopic*/diagnosis
Dermatitis, Atopic*/drug therapy
Antibodies, Monoclonal, Humanized*
Child ; Humans ; Child, Preschool ; Quality of Life ; Injections, Subcutaneous ; Double-Blind Method ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Hydrogel Based on Riclin Cross-Linked with Polyethylene Glycol Diglycidyl Ether as a Soft Filler for Tissue Engineering.
Autorzy:
Lu W; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Wang X; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Kong C; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Chen S; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Hu C; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Zhang J; Center for Molecular Metabolism, Nanjing University of Science & Technology, Nanjing 210094, China.; Key Laboratory of Metabolic Engineering and Biosynthesis Technology, Ministry of Industry and Information Technology, Nanjing 210094, China.
Pokaż więcej
Źródło:
Biomacromolecules [Biomacromolecules] 2024 Feb 12; Vol. 25 (2), pp. 1119-1132. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Tissue Engineering*
Hydrogels*
Animals ; Mice ; Injections, Subcutaneous ; Hyaluronic Acid ; Excipients ; Mice, Inbred BALB C ; Polyethylene Glycols ; Ethers
Czasopismo naukowe
Tytuł:
Lipolytic agents for submental fat reduction: Review.
Autorzy:
Park SY; Made-Young Plastic Surgery Clinic, Seoul, South Korea.
Kim SB; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
Wan J; Asia Pacific Aesthetic Academy, Seoul, Hong Kong.
Felice F; School of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina.
Yi KH; Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.; Maylin Clinic (Apgujeong), Seoul, South Korea.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Feb; Vol. 30 (2), pp. e13601.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adipose Tissue*
Cosmetic Techniques*
Humans ; Deoxycholic Acid/pharmacology ; Injections, Subcutaneous ; Aminophylline/pharmacology ; Subcutaneous Fat
Czasopismo naukowe
Tytuł:
Hot off the press: Subcutaneous insulin for mild to moderate diabetic ketoacidosis.
Autorzy:
Datta S; NYU Grossman Long Island School of Medicine, New York, New York, USA.
Bond C; Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.
Milne WK; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Pokaż więcej
Źródło:
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine [Acad Emerg Med] 2024 Feb; Vol. 31 (2), pp. 187-189. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Diabetic Ketoacidosis*/drug therapy
Diabetes Mellitus*
Humans ; Insulin/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Infusions, Intravenous ; Injections, Subcutaneous
Czasopismo naukowe
Tytuł:
Formulation and in vitro characterization of nanoemulsions containing remdesivir or licorice extract: A potential subcutaneous injection for coronavirus treatment.
Autorzy:
Al Ashmawy AZG; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt. Electronic address: zahraa_.
Balata GF; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44511, Egypt; Pharmacy Practice Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.
Pokaż więcej
Źródło:
Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2024 Feb; Vol. 234, pp. 113703. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Coronavirus*
Glycyrrhiza*
Plant Extracts*
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Emulsions/chemistry ; Surface-Active Agents/chemistry ; Oils ; Injections, Subcutaneous ; Particle Size
Czasopismo naukowe
Tytuł:
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial.
Autorzy:
Zhao Y; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
Zhang J; Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
Yang B; Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong 510091, China.
Li J; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Ding Y; Department of Dermatology, Shanghai Skin Disease Hospital, Institute of Psoriasis, Tongji University School of Medicine, Shanghai 200443, China.
Wu L; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China.
Zhang L; Department of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin 300120, China.
Wang J; Department of Dermatology, Ningbo No.2 Hospital, Ningbo, Zhejiang 315010, China.
Zhu X; Department of Dermatology, The Wuxi Second Affiliated Hospital of Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Zhang F; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Veneorology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250022, China.
Tao X; Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, China.
Li Y; Department of Dermatology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China.
Zhang C; Department of Dermatology, Peking University Third Hospital, Beijing 100191, China.
Li L; Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Lu J; Department of Dermatology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, China.
Diao Q; Department of Dermatology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400011, China.
Lu Q; Hunan Key Laboratory of Medical Epigenomics, Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Man X; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
Li F; Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin 130041, China.
Xia X; Department of Dermatology, Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital, Yantai, Shandong 264000, China.
Cheng H; Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, China.
Jia Y; Clinical Department, Keymed Biosciences (Chengdu) Limited, Chengdu, Sichuan 610219, China.
Zhao G; Clinical Department, Keymed Biosciences (Chengdu) Limited, Chengdu, Sichuan 610219, China.
Yan J; Clinical Department, Keymed Biosciences (Chengdu) Limited, Chengdu, Sichuan 610219, China.
Chen B; Clinical Department, Keymed Biosciences (Chengdu) Limited, Chengdu, Sichuan 610219, China.
Pokaż więcej
Źródło:
Chinese medical journal [Chin Med J (Engl)] 2024 Jan 20; Vol. 137 (2), pp. 200-208. Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Adult ; Humans ; Treatment Outcome ; Severity of Illness Index ; Antibodies, Monoclonal, Humanized/therapeutic use ; Injections, Subcutaneous ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access.
Autorzy:
Bittner B; Global Product Strategy, Product Optimization, F. Hoffmann-La Roche, Grenzacher Strasse 124, 4070, Basel, Switzerland. .
Schmidt J; Global Product Strategy, Product Optimization, F. Hoffmann-La Roche, Grenzacher Strasse 124, 4070, Basel, Switzerland.
Pokaż więcej
Źródło:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2024 Jan; Vol. 38 (1), pp. 23-46. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Multiple Sclerosis*/drug therapy
Biological Products*
Humans ; Antibodies, Monoclonal/therapeutic use ; Injections, Subcutaneous
Czasopismo naukowe
Tytuł:
Bone site fracture pain after subcutaneous sumatriptan injection: A report of two cases.
Autorzy:
Beltramone M; Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France.
Redon S; Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France.
Donnet A; Department of Evaluation and Treatment of Pain, FHU INOVPAIN, CHU Timone, AP-HM, Marseille, France.; INSERM U-1107, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
Pokaż więcej
Źródło:
Headache [Headache] 2024 Jan; Vol. 64 (1), pp. 117-118. Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Cluster Headache*/drug therapy
Migraine Disorders*/drug therapy
Humans ; Sumatriptan/adverse effects ; Pain/drug therapy ; Pain/etiology ; Injections, Subcutaneous
Raport
Tytuł:
[Effectiveness and interest of retrobulbar hyaluronidase injections in the treatment of blindness complicating facial hyaluronic acid injections: A literature review].
Autorzy:
Desbarats C; Service de chirurgie maxillo-faciale et stomatologie, CHU-Hôpitaux de Rouen, hôpital Charles-Nicolle, 1, rue de Germont, 76031 Rouen cedex, France. Electronic address: .
Derombise B; Service de chirurgie maxillo-faciale et stomatologie, CHU-Hôpitaux de Rouen, hôpital Charles-Nicolle, 1, rue de Germont, 76031 Rouen cedex, France.
Trost O; Service de chirurgie maxillo-faciale et stomatologie, CHU-Hôpitaux de Rouen, hôpital Charles-Nicolle, 1, rue de Germont, 76031 Rouen cedex, France; Laboratoire d'anatomie, UFR Santé de Rouen, université de Rouen-Normandie, 22, boulevard Gambetta, 76000 Rouen, France; CETAPS, EA3832, Research Center for Sports and Athletic Activities Transformations, University of Rouen Normandy, Mont-Saint-Aignan, France.
Pokaż więcej
Transliterated Title:
Efficacité et intérêt des injections rétrobulbaires de hyaluronidase dans le traitement des cécités compliquant une injection faciale d’acide hyaluronique : revue de la littérature.
Źródło:
Annales de chirurgie plastique et esthetique [Ann Chir Plast Esthet] 2024 Jan; Vol. 69 (1), pp. 63-69. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:
Review; English Abstract; Journal Article
MeSH Terms:
Dermal Fillers*/adverse effects
Cosmetic Techniques*/adverse effects
Humans ; Hyaluronic Acid/adverse effects ; Hyaluronoglucosaminidase/therapeutic use ; Injections/adverse effects ; Blindness/chemically induced ; Blindness/drug therapy ; Injections, Subcutaneous
Czasopismo naukowe
Tytuł:
Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease.
Autorzy:
Pang Y; Clinical Pharmacology, AbbVie, Inc, North Chicago, Illinois, USA. Electronic address: .
D'Cunha R; Clinical Pharmacology, AbbVie, Inc, North Chicago, Illinois, USA.
Mohammad AS; Clinical Pharmacology, AbbVie, Inc, North Chicago, Illinois, USA.
Wang Z; Statistics, AbbVie, Inc, North Chicago, Illinois, USA.
Duan R; Pharmacovigilance and Patient Safety, AbbVie, Inc, North Chicago, Illinois, USA.
Kalabic J; Clinical Development, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
Anschutz T; Clinical Development, Immunology, AbbVie, Inc, North Chicago, Illinois, USA.
Nudurupati S; Statistics, AbbVie, Inc, North Chicago, Illinois, USA.
Wallace K; Clinical Development, Immunology, AbbVie, Inc, North Chicago, Illinois, USA.
Jaeschke M; Development Science, AbbVie, Inc, North Chicago, Illinois, USA.
Nannapaneni S; Development Science, AbbVie, Inc, North Chicago, Illinois, USA.
Zhou J; Development Science, AbbVie, Inc, North Chicago, Illinois, USA.
Liu W; Clinical Pharmacology, AbbVie, Inc, North Chicago, Illinois, USA.
Marroum P; Clinical Pharmacology, AbbVie, Inc, North Chicago, Illinois, USA.
Pokaż więcej
Źródło:
Clinical therapeutics [Clin Ther] 2024 Jan; Vol. 46 (1), pp. 30-39. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Crohn Disease*/drug therapy
Humans ; Syringes ; Injections, Subcutaneous ; Antibodies, Monoclonal/therapeutic use
Czasopismo naukowe
Tytuł:
Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis.
Autorzy:
Yang B; School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Han L; School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wang Y; School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, China .
Cheng K; School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, China .
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Jan 11; Vol. 13 (1), pp. e063161. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Insulin*/administration & dosage
Insulin*/therapeutic use
Infusions, Subcutaneous*/methods
Injections, Subcutaneous*/methods
Aged ; Humans ; Glycemic Control ; Meta-Analysis as Topic ; Systematic Reviews as Topic ; Insulin Infusion Systems ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
A Pilot Study of Adolescent and Young Adult Experience with Subcutaneous Depot Medroxyprogesterone Acetate.
Autorzy:
Wernick HJ; Division of Adolescent Medicine, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: .
Wentzel E; Division of Adolescent Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Jackson K; The Ohio State University College of Medicine, Columbus, Ohio; Biostatistics Resource, Nationwide Children's Hospital, Columbus, Ohio.
Schmuhl K; Division of Adolescent Medicine, Nationwide Children's Hospital, Columbus, Ohio; The Ohio State University College of Pharmacy, Columbus, Ohio.
Valenti O; Center for Clinical Excellence, Nationwide Children's Hospital, Columbus, Ohio.
Bonny AE; Division of Adolescent Medicine, Nationwide Children's Hospital, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio.
Berlan ED; Division of Adolescent Medicine, Nationwide Children's Hospital, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio.
Pokaż więcej
Źródło:
Journal of pediatric and adolescent gynecology [J Pediatr Adolesc Gynecol] 2023 Dec; Vol. 36 (6), pp. 549-552. Date of Electronic Publication: 2023 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Medroxyprogesterone Acetate*/adverse effects
Contraceptive Agents, Female*/adverse effects
Child ; Humans ; Female ; Young Adult ; Adolescent ; Pilot Projects ; Injections, Subcutaneous ; Self Administration
Czasopismo naukowe
Tytuł:
A liquid crystal in situ gel based on rotigotine for the treatment of Parkinson's disease.
Autorzy:
Wu X; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China.; School of Pharmacy, Yantai University, Yantai, 264005, People's Republic of China.
Cheng D; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China. .; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, People's Republic of China. .
Lu Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China.; School of Pharmacy, Yantai University, Yantai, 264005, People's Republic of China.
Rong R; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, People's Republic of China.
Kong Y; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, People's Republic of China.
Wang X; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, People's Republic of China.
Niu B; Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai, 264000, Shandong, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, People's Republic of China.
Pokaż więcej
Źródło:
Drug delivery and translational research [Drug Deliv Transl Res] 2024 Apr; Vol. 14 (4), pp. 1048-1062. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Parkinson Disease*/drug therapy
Liquid Crystals*/chemistry
Tetrahydronaphthalenes*
Thiophenes*
Humans ; Rats ; Animals ; Scattering, Small Angle ; Rats, Sprague-Dawley ; X-Ray Diffraction ; Dopamine Agonists/adverse effects ; Injections, Subcutaneous ; Ethanol
Czasopismo naukowe
Tytuł:
A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults.
Autorzy:
Nagy A; Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.
Duff K; Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Bauer A; Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria.
Okonneh F; Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Rondon JC; Clinical Pharmacology of Miami, LLC, an Evolution Research Group portfolio company, Miami, FL, USA.
Yel L; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; University of California, Irvine, CA, USA.
Li Z; Takeda Development Center Americas, Inc., Cambridge, MA, USA. .
Pokaż więcej
Źródło:
Journal of clinical immunology [J Clin Immunol] 2023 Dec 22; Vol. 44 (1), pp. 28. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Hyaluronoglucosaminidase*/therapeutic use
Immunoglobulin G*/therapeutic use
Male ; Adult ; Humans ; Female ; Injections, Subcutaneous ; Infusions, Subcutaneous ; Clinical Protocols
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies